BCL-W expression is upregulated in certain cancer samples relative to normal tissues, such as some digestive tract malignancies [21, 22], as well as some Burkitt lymphomas (BLs), diffuse large B cell lymphomas (DLBCLs), and Hodgkin lymphomas (HLs) [23, 24]. This evidence concerns the gene BCL2L2 and Burkitt lymphoma.